Investors Asset Management of Georgia’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.68M | Sell |
18,592
-40
| -0.2% | -$8.61K | 1.63% | 13 |
|
|
2026
Q1 | $4.05M | Buy |
18,632
+63
| +0.3% | +$14K | 1.66% | 14 |
|
|
2025
Q4 | $4.24M | Buy |
18,569
+95
| +0.5% | +$21.6K | 1.75% | 13 |
|
|
2025
Q3 | $4.28M | Sell |
18,474
-147
| -0.8% | -$29.9K | 1.82% | 11 |
|
|
2025
Q2 | $3.46M | Buy |
18,621
+1,749
| +10% | +$325K | 1.6% | 11 |
|
|
2025
Q1 | $3.54M | Sell |
16,872
-490
| -3% | -$95.3K | 1.79% | 12 |
|
|
2024
Q4 | $3.09M | Sell |
17,362
-242
| -1% | -$44.5K | 1.5% | 14 |
|
|
2024
Q3 | $3.48M | Sell |
17,604
-342
| -2% | -$63.8K | 1.64% | 14 |
|
|
2024
Q2 | $3.08M | Sell |
17,946
-82
| -0.5% | -$13.6K | 1.5% | 15 |
|
|
2024
Q1 | $3.28M | Sell |
18,028
-170
| -0.9% | -$29.3K | 1.54% | 15 |
|
|
2023
Q4 | $2.82M | Sell |
18,198
-140
| -0.8% | -$20.4K | 1.43% | 15 |
|
|
2023
Q3 | $2.7M | Buy |
18,338
+260
| +1% | +$38.2K | 1.49% | 13 |
|
|
2023
Q2 | $2.44M | Sell |
18,078
-1,480
| -8% | -$217K | 1.26% | 15 |
|
|
2023
Q1 | $3.12M | Buy |
19,558
+75
| +0.4% | +$11.5K | 1.66% | 12 |
|
|
2022
Q4 | $3.15M | Sell |
19,483
-233
| -1% | -$35.7K | 1.64% | 13 |
|
|
2022
Q3 | $2.65M | Buy |
19,716
+505
| +3% | +$72.5K | 1.36% | 14 |
|
|
2022
Q2 | $2.94M | Sell |
19,211
-355
| -2% | -$54.2K | 1.53% | 13 |
|
|
2022
Q1 | $3.17M | Buy |
19,566
+75
| +0.4% | +$10.9K | 1.6% | 11 |
|
|
2021
Q4 | $2.64M | Sell |
19,491
-80
| -0.4% | -$9.45K | 1.26% | 14 |
|
|
2021
Q3 | $2.11M | Buy |
19,571
+1,945
| +11% | +$222K | 1.1% | 17 |
|
|
2021
Q2 | $1.99M | Sell |
17,626
-50
| -0.3% | -$5.63K | 1.07% | 18 |
|
|
2021
Q1 | $1.91M | Buy |
17,676
+365
| +2% | +$39K | 1.11% | 19 |
|
|
2020
Q4 | $1.85M | Sell |
17,311
-475
| -3% | -$45.6K | 1.25% | 16 |
|
|
2020
Q3 | $1.56M | Buy |
17,786
+50
| +0.3% | +$4.71K | 1.04% | 20 |
|
|
2020
Q2 | $1.74M | Sell |
17,736
-313
| -2% | -$27.6K | 1.21% | 12 |
|
|
2020
Q1 | $1.38M | Buy |
18,049
+1,050
| +6% | +$89.4K | 1.12% | 20 |
|
|
2019
Q4 | $1.5M | Sell |
16,999
-450
| -3% | -$37.4K | 0.91% | 26 |
|
|
2019
Q3 | $1.32M | Buy |
17,449
+150
| +0.9% | +$10.3K | 0.84% | 28 |
|
|
2019
Q2 | $1.26M | Buy |
17,299
+6,823
| +65% | +$536K | 0.85% | 27 |
|
|
2019
Q1 | $844K | Buy |
10,476
+60
| +0.6% | +$4.91K | 0.59% | 44 |
|
|
2018
Q4 | $960K | Sell |
10,416
-315
| -3% | -$27.7K | 0.78% | 29 |
|
|
2018
Q3 | $1.01M | Buy |
10,731
+100
| +0.9% | +$9.48K | 0.71% | 37 |
|
|
2018
Q2 | $985K | Buy |
10,631
+564
| +6% | +$55.1K | 0.72% | 39 |
|
|
2018
Q1 | $953K | Sell |
10,067
-250
| -2% | -$27.5K | 0.71% | 38 |
|
|
2017
Q4 | $998K | Sell |
10,317
-1,103
| -10% | -$104K | 0.71% | 38 |
|
|
2017
Q3 | $1.01M | Buy |
11,420
+525
| +5% | +$40K | 0.75% | 34 |
|
|
2017
Q2 | $790K | Buy |
10,895
+100
| +0.9% | +$6.72K | 0.54% | 43 |
|
|
2017
Q1 | $703K | Buy |
10,795
+325
| +3% | +$20.4K | 0.49% | 49 |
|
|
2016
Q4 | $656K | Buy |
10,470
+660
| +7% | +$40.3K | 0.49% | 51 |
|
|
2016
Q3 | $619K | Hold |
9,810
| – | – | 0.47% | 51 |
|
|
2016
Q2 | $607K | Buy |
9,810
+800
| +9% | +$48.7K | 0.47% | 47 |
|
|
2016
Q1 | $515K | Buy |
9,010
+830
| +10% | +$46.3K | 0.43% | 53 |
|
|
2015
Q4 | $485K | Buy |
8,180
+2,810
| +52% | +$162K | 0.41% | 54 |
|
|
2015
Q3 | $292K | Buy |
5,370
+370
| +7% | +$24.1K | 0.26% | 90 |
|
|
2015
Q2 | $336K | Buy |
5,000
+530
| +12% | +$34.6K | 0.29% | 82 |
|
|
2015
Q1 | $262K | Hold |
4,470
| – | – | 0.22% | 102 |
|
|
2014
Q4 | $293K | Buy |
+4,470
| New | +$282K | 0.25% | 95 |
|
Other funds holding ABBV
Investors Asset Management of Georgia's ABBV Position: Q2 2026 in Review
Investors Asset Management of Georgia reduced its AbbVie (ABBV) stake by 0.21% in Q2 2026, selling an estimated $8.61K and leaving 18,592 shares worth $4.68M. The position accounts for 1.63% of the portfolio, ranked #13.
Investors Asset Management of Georgia first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Investors Asset Management of Georgia held 18,592 shares of AbbVie worth $4.68M as of Q2 2026.
- Investors Asset Management of Georgia sold 40 AbbVie shares in Q2 2026, an estimated $8.61K.
- AbbVie made up 1.63% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #13 holding.
- Investors Asset Management of Georgia first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.